We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-1.85%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+676.14%
AUM
$865B
AUM Growth
-$62.5B
Cap. Flow
-$15.6B
Cap. Flow %
-1.8%
Top 10 Hldgs %
34.38%
Holding
3,202
New
115
Increased
2,022
Reduced
804
Closed
71

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$1.82B
2
SE icon
Sea Limited
SE
+$1.38B
3
CSCO icon
Cisco
CSCO
+$1.16B
4
NFLX icon
Netflix
NFLX
+$1.14B
5
IR icon
Ingersoll Rand
IR
+$1.03B

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.54B
2
AMZN icon
Amazon
AMZN
+$1.75B
3
APH icon
Amphenol
APH
+$1.65B
4
KLAC icon
KLA
KLAC
+$1.5B
5
XEL icon
Xcel Energy
XEL
+$1.38B

Sector Composition

Rank Sector Weight
1 Technology 33.6%
2 Financials 11.17%
3 Healthcare 11.1%
4 Communication Services 10.25%
5 Consumer Discretionary 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SION
926
Sionna Therapeutics
SION
$2.08B
$30.3M ﹤0.01%
756,376
-74,997
-9% -$2.86M
PFGC icon
927
Performance Food Group
PFGC
$17.9B
$30.3M ﹤0.01%
353,174
-64,603
-15% -$5.91M
STZ icon
928
Constellation Brands
STZ
$22.3B
$30.2M ﹤0.01%
201,481
-9,668
-5% -$1.49M
CELH icon
929
Celsius Holdings
CELH
$7.32B
$30.2M ﹤0.01%
850,606
+197,134
+30% +$9.35M
CRUS icon
930
Cirrus Logic
CRUS
$6.85B
$30.1M ﹤0.01%
208,382
-68,172
-25% -$9.17M
CCEP icon
931
Coca-Cola Europacific Partners
CCEP
$48B
$30.1M ﹤0.01%
331,689
+43,511
+15% +$4.18M
ACA icon
932
Arcosa
ACA
$7.13B
$30M ﹤0.01%
282,398
+154,201
+120% +$17.5M
IESC icon
933
IES Holdings
IESC
$12B
$29.7M ﹤0.01%
62,236
+1,415
+2% +$649K
HIMS icon
934
Hims & Hers Health
HIMS
$7B
$29.4M ﹤0.01%
1,417,344
+690,857
+95% +$16.3M
GEN icon
935
Gen Digital
GEN
$16.2B
$29.4M ﹤0.01%
1,561,870
-411,669
-21% -$9.53M
ERAS icon
936
Erasca
ERAS
$6.64B
$29.4M ﹤0.01%
1,815,340
+1,711,837
+1,654% +$20.2M
LDOS icon
937
Leidos
LDOS
$14.4B
$29M ﹤0.01%
186,749
-94,714
-34% -$17M
LEU icon
938
Centrus Energy
LEU
$3.39B
$29M ﹤0.01%
167,195
-204,627
-55% -$49.4M
CGEM icon
939
Cullinan Oncology
CGEM
$1.1B
$28.8M ﹤0.01%
2,029,719
+1,982,532
+4,201% +$25.5M
COCO icon
940
Vita Coco
COCO
$3.86B
$28.7M ﹤0.01%
598,008
-550,445
-48% -$30M
PNFP icon
941
Pinnacle Financial Partners Inc
PNFP
$15.6B
$28.6M ﹤0.01%
331,467
+263,982
+391% +$24.6M
BJ icon
942
BJs Wholesale Club
BJ
$12.2B
$28.5M ﹤0.01%
289,845
-122,360
-30% -$11.8M
GIS icon
943
General Mills
GIS
$19.6B
$28.4M ﹤0.01%
763,206
-133,393
-15% -$5.79M
ATAT icon
944
Atour Lifestyle Holdings
ATAT
$4.56B
$28.3M ﹤0.01%
767,459
+719,376
+1,496% +$27.1M
GLNG icon
945
Golar LNG
GLNG
$4.88B
$28.1M ﹤0.01%
519,758
+463,565
+825% +$20.5M
KHC icon
946
Kraft Heinz
KHC
$31.2B
$28.1M ﹤0.01%
1,249,298
-11,924
-0.9% -$280K
WRB icon
947
W.R. Berkley
WRB
$28.1B
$28M ﹤0.01%
423,154
-5,092
-1% -$351K
AKTS
948
Aktis Oncology
AKTS
$1.38B
$28M ﹤0.01%
+1,564,196
New +$30.4M
ZM icon
949
Zoom
ZM
$26.7B
$27.9M ﹤0.01%
347,433
+88,353
+34% +$7.4M
OKTA icon
950
Okta
OKTA
$24.1B
$27.8M ﹤0.01%
353,297
-355,067
-50% -$29.5M

Similar funds

T. Rowe Price Associates's Q1 2026 Portfolio in Review

As of Q1 2026, T. Rowe Price Associates held 3,202 positions worth $865B, down 6.7% from $927B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

T. Rowe Price Associates's Q1 2026 filing shows 115 new, 2,022 increased, 804 reduced and 71 closed positions. Its largest new stake was Cenovus Energy: 23,907,299 shares worth $634M. The largest sale was Microsoft, an estimated $3.54B.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.

  • T. Rowe Price Associates's largest Q1 2026 buy was Cenovus Energy: 23,907,299 shares worth $634M.
  • T. Rowe Price Associates added most to Advanced Micro Devices in Q1 2026, an estimated $1.82B increase.
  • T. Rowe Price Associates's biggest Q1 2026 reduction was Microsoft, cutting an estimated $3.54B.
  • T. Rowe Price Associates fully exited CyberArk in Q1 2026, selling an estimated $251M.
  • T. Rowe Price Associates's ten largest holdings make up 34% of its $865B portfolio in Q1 2026.
  • T. Rowe Price Associates opened 115 new positions and closed 71 in Q1 2026.
  • T. Rowe Price Associates's portfolio value fell 6.7% quarter-over-quarter to $865B.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.